Vigilant Capital Management LLC lowered its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 26.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 279 shares of the medical research company’s stock after selling 100 shares during the quarter. Vigilant Capital Management LLC’s holdings in Thermo Fisher Scientific were worth $76,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Capital Financial Planning LLC bought a new position in Thermo Fisher Scientific during the 4th quarter worth $27,000. Hanson McClain Inc. grew its stake in shares of Thermo Fisher Scientific by 263.9% in the 4th quarter. Hanson McClain Inc. now owns 131 shares of the medical research company’s stock valued at $29,000 after buying an additional 95 shares during the period. CX Institutional acquired a new stake in shares of Thermo Fisher Scientific in the 1st quarter valued at about $36,000. Capital Investment Advisory Services LLC acquired a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at about $35,000. Finally, Liberty Wealth Management LLC acquired a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at about $35,000. 88.66% of the stock is currently owned by institutional investors and hedge funds.
In related news, CAO Peter E. Hornstra sold 5,920 shares of Thermo Fisher Scientific stock in a transaction dated Friday, February 15th. The shares were sold at an average price of $250.00, for a total transaction of $1,480,000.00. Following the completion of the transaction, the chief accounting officer now directly owns 17,057 shares of the company’s stock, valued at approximately $4,264,250. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Gregory J. Herrema sold 3,299 shares of Thermo Fisher Scientific stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $263.05, for a total transaction of $867,801.95. The disclosure for this sale can be found here. Insiders sold a total of 36,927 shares of company stock valued at $9,388,124 over the last three months. Corporate insiders own 0.49% of the company’s stock.
A number of research firms have issued reports on TMO. Bank of America reiterated a “buy” rating and set a $300.00 price target (up previously from $285.00) on shares of Thermo Fisher Scientific in a research note on Tuesday. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $310.00 target price on the stock in a research report on Tuesday, April 9th. Deutsche Bank lifted their price target on shares of Thermo Fisher Scientific from $275.00 to $300.00 and gave the stock a “buy” rating in a report on Friday, March 22nd. Robert W. Baird boosted their target price on shares of Thermo Fisher Scientific from $270.00 to $288.00 and gave the company an “outperform” rating in a report on Tuesday, March 26th. Finally, BTIG Research boosted their price target on shares of Thermo Fisher Scientific to $310.00 and gave the company a “buy” rating in a research report on Tuesday, March 26th. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $289.92.
NYSE TMO traded down $3.67 during trading on Wednesday, hitting $263.16. 37,617 shares of the company’s stock traded hands, compared to its average volume of 1,255,318. The firm has a market cap of $110.75 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 1.83 and a beta of 1.13. The company has a quick ratio of 1.24, a current ratio of 1.73 and a debt-to-equity ratio of 0.64. Thermo Fisher Scientific Inc. has a 12-month low of $202.83 and a 12-month high of $282.98.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, January 30th. The medical research company reported $3.25 EPS for the quarter, beating the consensus estimate of $3.19 by $0.06. Thermo Fisher Scientific had a net margin of 12.06% and a return on equity of 16.86%. The firm had revenue of $6.51 billion during the quarter, compared to the consensus estimate of $6.26 billion. During the same period in the prior year, the firm posted $2.79 earnings per share. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. Equities analysts expect that Thermo Fisher Scientific Inc. will post 12.15 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 16th. Shareholders of record on Friday, March 15th were paid a $0.19 dividend. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend was Thursday, March 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 6.83%.
ILLEGAL ACTIVITY NOTICE: “Vigilant Capital Management LLC Cuts Stake in Thermo Fisher Scientific Inc. (TMO)” was first published by XNewsPress and is the sole property of of XNewsPress. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://xnewspress.com/news/2019/04/17/vigilant-capital-management-llc-sells-100-shares-of-thermo-fisher-scientific-inc-tmo.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Recommended Story: Calculating net profit and net profit margin ratio
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.